Previous 10 | Next 10 |
Allena Pharmaceuticals (ALNA) inks agreements with several institutional and accredited investors for the purchase and sale of 21,357,744 common shares and warrants to purchase up to 10,678,872 common stock, at $1.311/share and warrant, in a registered direct offering priced at-the-market.Exp...
NEWTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...
Allena Pharmaceuticals ([[ALNA]]) provides progress updates on its clinical programs: ALLN-346 in development for the treatment of patients with hyperuricemia and gout in the setting of chronic kidney disease ((CKD)) and reloxaliase (ALLN-177) in development for the treatment of patients with...
-ALLN-346 successfully completes Phase 1b safety study; on track to start two Phase 2a studies in Q3 2021 with initial data expected in Q4 2021- -Reloxaliase advancing in URIROX-2 Pivotal Phase 3 study; revised interim analysis now targeted for Q1 2022- NEWTON, Mass., July...
NEWTON, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and ki...
NEWTON, Mass., June 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...
Penny Stocks Are Popular Right Now, Here Are 5 to Watch If your goal is to make quick returns in the stock market, penny stocks may be the right investment for you. While long-term investing with penny stocks is possible, short-term or swing trading is much more common. Nevertheless...
-- Enrollment ongoing in Phase 3 URIROX-2 clinical trial of reloxaliase; interim analysis expected 2Q or 3Q 2022 -- -- Enrolling healthy volunteers in Phase 1b MAD study of ALLN-346; initial data expected 3Q 2021 -- -- On-track to initiate Phase 2a program for ALLN-346 in 3Q 2...
Allena Pharmaceuticals Inc. (NASDAQ:ALNA) traded at a new 52-week low today of $1.06. Approximately 4.3 million shares have changed hands today, as compared to an average 30-day volume of 812,000 shares. Allena Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engage...
NEWTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney d...
News, Short Squeeze, Breakout and More Instantly...
Allena Pharmaceuticals Inc. Company Name:
ALNA Stock Symbol:
NASDAQ Market:
Allena Pharmaceuticals Inc. Website:
Buying Penny Stocks on July 29th? Here’s What You Need to Know If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. As a result, it all comes down to finding the best penny stocks that fit your trading strateg...
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme the...
NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...